Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 634 | 3 | INSULIN RECEPTOR//GLUT4//GLYCOSYLPHOSPHATIDYLINOSITOL | 12210 |
| 1014 | 2 | INSULIN RECEPTOR//GLUT4//GLYCOSYLPHOSPHATIDYLINOSITOL | 10638 |
| 30973 | 1 | AURON MISHEIL THERAPY//AURON MISHIEL THERAPY//CENTER PUBL HLTH GENOM | 174 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | AURON MISHEIL THERAPY | authKW | 407545 | 2% | 75% | 3 |
| 2 | AURON MISHIEL THERAPY | authKW | 181132 | 1% | 100% | 1 |
| 3 | CENTER PUBL HLTH GENOM | address | 181132 | 1% | 100% | 1 |
| 4 | GRACE DRUG CANC PHARMACOL | address | 181132 | 1% | 100% | 1 |
| 5 | IG1 RECEPTOR | authKW | 181132 | 1% | 100% | 1 |
| 6 | INSULIN ENHANCED ANTITUMOR RESPONSE | authKW | 181132 | 1% | 100% | 1 |
| 7 | INSULIN POTENTIAL THERAPY | authKW | 181132 | 1% | 100% | 1 |
| 8 | INSULIN RELATED GROWTH FACTORS | authKW | 181132 | 1% | 100% | 1 |
| 9 | INSULIN RELATED SUBSTANCE | authKW | 181132 | 1% | 100% | 1 |
| 10 | JORDANOVAC CLIN PULM DIS TB | address | 181132 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Endocrinology & Metabolism | 442 | 20% | 0% | 35 |
| 2 | Oncology | 223 | 20% | 0% | 35 |
| 3 | Immunology | 94 | 13% | 0% | 22 |
| 4 | Medicine, Research & Experimental | 94 | 10% | 0% | 17 |
| 5 | Hematology | 27 | 5% | 0% | 8 |
| 6 | Cell Biology | 24 | 8% | 0% | 14 |
| 7 | CYTOLOGY & HISTOLOGY | 22 | 1% | 0% | 1 |
| 8 | Medicine, General & Internal | 17 | 6% | 0% | 11 |
| 9 | Geriatrics & Gerontology | 12 | 2% | 0% | 3 |
| 10 | Biochemistry & Molecular Biology | 12 | 11% | 0% | 20 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CENTER PUBL HLTH GENOM | 181132 | 1% | 100% | 1 |
| 2 | GRACE DRUG CANC PHARMACOL | 181132 | 1% | 100% | 1 |
| 3 | JORDANOVAC CLIN PULM DIS TB | 181132 | 1% | 100% | 1 |
| 4 | TUMORKLIN SANAFONTIS | 181132 | 1% | 100% | 1 |
| 5 | NEUROSCI DOCTORAL SUBPROGRAM | 90565 | 1% | 50% | 1 |
| 6 | FRANK RIDDICK DIABET | 72450 | 1% | 20% | 2 |
| 7 | BIJENICKA C 54 | 60376 | 1% | 33% | 1 |
| 8 | CANTERBURY REG CANC BLOOD SERV | 45281 | 1% | 25% | 1 |
| 9 | STATE PHARMACOL BIOTECHNOL | 45281 | 1% | 25% | 1 |
| 10 | BIJENICKA 54 | 36225 | 1% | 20% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BIOMEDICINE EXPRESS | 1587 | 1% | 1% | 1 |
| 2 | PERIODICUM BIOLOGORUM | 1324 | 2% | 0% | 4 |
| 3 | DIABETES | 1195 | 5% | 0% | 9 |
| 4 | TUMORDIAGNOSTIK & THERAPIE | 928 | 1% | 0% | 2 |
| 5 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 861 | 2% | 0% | 3 |
| 6 | RESEARCH IN EXPERIMENTAL MEDICINE | 773 | 1% | 0% | 2 |
| 7 | BLUT | 766 | 1% | 0% | 2 |
| 8 | BIOMATERIALS ARTIFICIAL CELLS AND IMMOBILIZATION BIOTECHNOLOGY | 720 | 1% | 0% | 1 |
| 9 | HORMONE AND METABOLIC RESEARCH | 703 | 3% | 0% | 5 |
| 10 | ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA | 674 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |